Literature DB >> 21924311

Localization and function of adenosine receptor subtypes at the longitudinal muscle--myenteric plexus of the rat ileum.

Cátia Vieira1, Fátima Ferreirinha, Isabel Silva, Margarida Duarte-Araújo, Paulo Correia-de-Sá.   

Abstract

Adenosine plays a dual role on acetylcholine (ACh) release from myenteric motoneurons via the activation of high-affinity inhibitory A₁ and facilitatory A(2A) receptors. The therapeutic potential of adenosine-related compounds for controlling intestinal motility and inflammation, prompted us to investigate further the role of low-affinity adenosine receptors, A(2B) and A₃, on electrically-evoked (5 Hz, 200 pulses) [³H]ACh release from myenteric neurons. Immunolocalization studies showed that A(2B) receptors exhibit a pattern of distribution similar to the glial cell marker, GFAP. Regarding A₁ and A₃ receptors, they are mainly distributed to cell bodies of ganglionic myenteric neurons, whereas A(2A) receptors are localized predominantly on cholinergic nerve terminals. Using selective antagonists (DPCPX, ZM241385 and MRS1191), data indicate that modulation of evoked [³H]ACh release is balanced through tonic activation of inhibitory (A₁) and facilitatory (A(2A) and A₃) receptors by endogenous adenosine. The selective A(2B) receptor antagonist, PSB603, alone was devoid of effect and failed to modify the inhibitory effect of NECA. The A₃ receptor agonist, 2-Cl-IB MECA (1-10 nM), concentration-dependently increased the release of [³H]ACh. The effect of 2-Cl-IB MECA was attenuated by MRS1191 and by ZM241385, which selectively block respectively A₃ and A(2A) receptors. In contrast to 2-Cl-IB MECA, activation of A(2A) receptors with CGS21680C attenuated nicotinic facilitation of ACh release induced by focal depolarization of myenteric nerve terminals in the presence of tetrodotoxin. Tandem localization of excitatory A₃ and A(2A) receptors along myenteric neurons explains why stimulation of A₃ receptors (with 2-Cl-IB MECA) on nerve cell bodies acts cooperatively with prejunctional facilitatory A(2A) receptors to up-regulate acetylcholine release. The results presented herein consolidate and expand the current understanding of adenosine receptor distribution and function in the myenteric plexus of the rat ileum, and should be taken into consideration for data interpretation regarding the pathophysiological implications of adenosine on intestinal motility disorders.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21924311     DOI: 10.1016/j.neuint.2011.08.016

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  11 in total

1.  The ecto-enzymes CD73 and adenosine deaminase modulate 5'-AMP-derived adenosine in myofibroblasts of the rat small intestine.

Authors:  Anna Bin; Valentina Caputi; Michela Bistoletti; Monica Montopoli; Rocchina Colucci; Luca Antonioli; Sara De Martin; Ignazio Castagliuolo; Genny Orso; Cristina Giaroni; Patrizia Debetto; Maria Cecilia Giron
Journal:  Purinergic Signal       Date:  2018-09-29       Impact factor: 3.765

Review 2.  Enteric glia: the most alimentary of all glia.

Authors:  Vladimir Grubišić; Brian D Gulbransen
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

Review 3.  Enteric glia regulate gut motility in health and disease.

Authors:  Vladimir Grubišić; Alexei Verkhratsky; Robert Zorec; Vladimir Parpura
Journal:  Brain Res Bull       Date:  2017-03-29       Impact factor: 4.077

4.  Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats.

Authors:  L Antonioli; M Fornai; O Awwad; G Giustarini; C Pellegrini; M Tuccori; V Caputi; M Qesari; I Castagliuolo; P Brun; M C Giron; C Scarpignato; C Blandizzi; R Colucci
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 5.  Purinergic signalling in the gastrointestinal tract and related organs in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-12-04       Impact factor: 3.765

6.  Adenosine-mediated enteric neuromuscular function is affected during herpes simplex virus type 1 infection of rat enteric nervous system.

Authors:  Chiara Zoppellaro; Anna Bin; Paola Brun; Serena Banzato; Veronica Macchi; Ignazio Castagliuolo; Maria Cecilia Giron
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

7.  Deficits in endogenous adenosine formation by ecto-5'-nucleotidase/CD73 impair neuromuscular transmission and immune competence in experimental autoimmune myasthenia gravis.

Authors:  Laura Oliveira; Alexandra Correia; Ana Cristina Costa; Sónia Guerra-Gomes; Fátima Ferreirinha; Maria Teresa Magalhães-Cardoso; Manuel Vilanova; Paulo Correia-de-Sá
Journal:  Mediators Inflamm       Date:  2015-01-27       Impact factor: 4.711

8.  Post-inflammatory Ileitis Induces Non-neuronal Purinergic Signaling Adjustments of Cholinergic Neurotransmission in the Myenteric Plexus.

Authors:  Cátia Vieira; Fátima Ferreirinha; Maria T Magalhães-Cardoso; Isabel Silva; Patrícia Marques; Paulo Correia-de-Sá
Journal:  Front Pharmacol       Date:  2017-11-08       Impact factor: 5.810

9.  Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity.

Authors:  Vanessa D'Antongiovanni; Laura Benvenuti; Matteo Fornai; Carolina Pellegrini; Renè van den Wijngaard; Silvia Cerantola; Maria Cecilia Giron; Valentina Caputi; Rocchina Colucci; Gyorgy Haskó; Zoltán H Németh; Corrado Blandizzi; Luca Antonioli
Journal:  Cells       Date:  2020-05-18       Impact factor: 6.600

10.  Feed-forward inhibition of CD73 and upregulation of adenosine deaminase contribute to the loss of adenosine neuromodulation in postinflammatory ileitis.

Authors:  Cátia Vieira; Maria Teresa Magalhães-Cardoso; Fátima Ferreirinha; Isabel Silva; Ana Sofia Dias; Julie Pelletier; Jean Sévigny; Paulo Correia-de-Sá
Journal:  Mediators Inflamm       Date:  2014-08-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.